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Control over ionic composition and volume of the inner ear luminal ﬂuid endolymph is essential for
normal hearing and balance. Mice deﬁcient in either the EphB2 receptor tyrosine kinase or the cognate
transmembrane ligand ephrin-B2 (Efnb2) exhibit background strain-speciﬁc vestibular-behavioral
dysfunction and signs of abnormal endolymph homeostasis. Using various loss-of-function mouse
models, we found that Efnb2 is required for growth and morphogenesis of the embryonic endolymphatic
epithelium, a precursor of the endolymphatic sac (ES) and duct (ED), which mediate endolymph
homeostasis. Conditional inactivation of Efnb2 in early-stage embryonic ear tissues disrupted cell
proliferation, cell survival, and epithelial folding at the origin of the endolymphatic epithelium. This
correlated with apparent absence of an ED, mis-localization of ES ion transport cells relative to inner ear
sensory organs, dysplasia of the endolymph ﬂuid space, and abnormally formed otoconia (extracellular
calcite-protein composites) at later stages of embryonic development. A comparison of Efnb2 and Notch
signaling-deﬁcient mutant phenotypes indicated that these two signaling systems have distinct and non-
overlapping roles in ES/ED development. Homozygous deletion of the Efnb2 C-terminus caused
abnormalities similar to those found in the conditional Efnb2 null homozygote. Analyses of fetal Efnb2
C-terminus deletion heterozygotes found mis-localized ES ion transport cells only in the genetic
background exhibiting vestibular dysfunction. We propose that developmental dysplasias described
here are a gene dose-sensitive cause of the vestibular dysfunction observed in EphB–Efnb2 signaling-
deﬁcient mice.
Published by Elsevier Inc.
Introduction
The inner ear comprises a ﬂuid-ﬁlled epithelium within a
labyrinthine space of the temporal bone. A prevalent inner ear
malformation is the Enlarged Vestibular Aqueduct (EVA; OMIM
600791). EVA is diagnosed by radiological identiﬁcation of a
dilated bony canal for the endolymphatic duct (ED) (Valvassori
and Clemis 1978). The ED is a soft tissue structure joining an
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absorptive/secretory transport epithelium, the endolymphatic sac
(ES) (Salt 2001), to the rest of the inner ear epithelium. Dilation of
ES and ED epithelia is thought to cause the bony malformation
pathognomonic for EVA. EVA is associated with a distinctive
clinical phenotype involving progressive hearing loss of early
onset and, less frequently, vestibular dysfunction [reviewed in
Grifﬁth and Wangemann (2011), Ito et al. (2011) and Dror et al.
(2011)].
Roughly one-half of EVA patients carry one or two mutant
alleles of the SLC26A4 gene (Grifﬁth and Wangemann 2011; Ito
et al., 2011; Dror et al., 2011), which encodes the protein pendrin,
an electroneutral exchanger of anions such as HCO3 , Cl , and I
(Lang et al., 2007). Studies of the ear in targeted mouse mutants
that lack functional pendrin have uncovered a pathological cas-
cade involving dilation of the ﬂuid-ﬁlled ear epithelium, altered
ionic composition of the luminal ﬂuid endolymph, malformation
of acellular matrix structures (otoconia), changes in protein
expression, metabolic stress, and post-natal death of the ear’s
primary sensory (hair) cells (Everett et al., 2001; Royaux et al.,
2003; Nakaya et al., 2007; Dror et al., 2010; Kim and Wangemann
2011; Singh and Wangemann 2008). Conditional genetic and gene
replacement strategies in the mouse indicate that these pheno-
types result from loss of pendrin at the ES during late embryonic
stages (Li et al., 2013; Choi et al., 2011). Furthermore, mice lacking
Foxi1, a forkhead transcription factor that activates Slc26a4 tran-
scription at the ES but not at other ear epithelia, have an inner ear
phenotype similar to that of Slc26a4/ mice (Hulander et al.,
2003). These and other results (Lorente-Canovas et al., 2012;
Norgett et al., 2012; Karet et al., 1999) indicate that mammalian
ear development requires ion transport at the prenatal ES.
The ES and ED derive from the primitive ear (otic) epithelium,
which is initially patterned by extrinsic signals from neighboring
embryonic structures. Reverse genetic and embryological studies
deﬁne a genetic hierarchy for the early stage speciﬁcation or
growth of an ES/ED rudiment from the otic epithelium: rhombo-
mere patterning by Hoxa1 and Mafb/kr positions a hindbrain
source of Fibrobast Growth Factor (Fgf3) signaling, which main-
tains Wnt-dependent expression of the homeobox-containing
gene Gbx2 in the otic epithelium (Pasqualetti et al., 2001; Choo
et al., 2006; Riccomagno et al., 2005; Ohyama et al., 2006; Pirvola
et al., 2000; Mansour et al., 1993; Hatch et al., 2007; Lin et al.,
2005). Mice lacking any of these genes lack an ES/ED epithelium
and have a dilated, dysmorphic inner ear. Gbx2 is required for
proper otic expression of the homeobox-containing gene, Dlx5 (Lin
et al., 2005), and mice lacking Dlx5 show moderately impaired
growth of the ES/ED (Depew et al., 1999; Acampora et al., 1999;
Merlo et al., 2002; Sajan et al., 2011). These and other (Gerlach-
Bank et al., 2003) results offer insight into early ES/ED growth, but
the question of how the endolymphatic epithelium differentiates
into a sac and duct with apparently distinct physiological roles has
not been addressed.
Eph receptor tyrosine kinases and their transmembrane
ephrin-B ligands comprise a group of cell contact-mediated
signaling molecules (Gale et al., 1996). Eph–ephrin signaling is
bidirectional (transduction occurs in both receptor- and ligand-
bearing cells) (Cowan and Henkemeyer, 2002) and pleiotropic in
its developmental roles. Eph–ephrin signaling mediates axon
guidance and topographic mapping, cell migration and prolifera-
tion, tissue boundary formation and segmentation, and epithelial
morphogenesis [reviewed in Klein (2012), Batlle and Wilkinson
(2012), Genander and Frisen (2010) and Feldheim and O’Leary
(2010). Eph–ephrin signaling also inﬂuences synaptogenesis and
synaptic plasticity through biochemical effects on ligand-gated ion
channel activity [reviewed in Xu and Henkemeyer (2012) and
Klein (2008)]. Mice heterozygous for deletion of the ephrin-B2
(Efnb2) C-terminus or homozygous for Ephb2 mutant alleles show
background strain-speciﬁc, incompletely penetrant vestibular-
behavioral dysfunction and altered ionic composition of endo-
lymph ﬂuid (Cowan et al., 2000; Dravis et al., 2007). Efnb2 C-
terminal deletion heterozygotes have mildly elevated auditory
brainstem response thresholds (Miko et al., 2008). Biochemical
evidence indicates that EphB2 and ephrinB C-termini recognize
cytoplasmic domains of anion exchangers and aquaporins through
PDZ domain containing proteins (Cowan et al., 2000). Ephb2 and
Efnb2 mRNA or gene products are found at sites of inner ear ion
transport in late fetal and post-natal mice (Cowan et al., 2000;
Dravis et al., 2007; Pickles et al., 2002; Zhou et al., 2011) and in the
earlier-stage otic epithelium before differentiation of transport
epithelia (Cowan et al., 2000; Henkemeyer et al., 1994).
The question of how EphB–Efnb2 signaling inﬂuences inner ear
ﬂuid physiology has remained unanswered. Here, we report on the
use of Cre-mediated conditional gene inactivation in the mouse to
circumvent early embryonic lethality and show that Efnb2 is
required for normal proliferation of early-stage inner ear epithelial
cells, timely outgrowth and morphogenesis of the endolymphatic
epithelium, and proper localization of pendrinþ/Foxi1þ ES ion
transport cells (mitochondrion-rich cells, or MRCs) relative to
sensory organs of the ear. In Efnb2 heterozygote mutants, mis-
localization of ion transport cells was found only in a genetic
background with reported vestibular dysfunction.
Results
Efnb2 loss-of-function causes dysplasia of the endolymphatic duct
and sac
We used the targeted alleles Sox9-IRES-Cre (Akiyama et al.,
2005), Efnb2-exon1-ﬂoxed (Gerety and Anderson, 2002), and
Efnb2-tau-lacZ (Wang et al., 1998) to effectively inactivate Efnb2
in early-stage otic epithelium, peri-otic mesenchyme, and bran-
chial arch mesenchyme, while avoiding Cre-mediated recombina-
tion in embryonic arteries and tissues with known or suspected
inductive inﬂuences on the developing ear (Fig. 1A–D). Efnb2
inactivation was conﬁrmed by immunoﬂuorescence and in situ
hybridization with an exon 1-speciﬁc probe (Fig. 1E–J). Live
isogenic C57BL/6 Sox9-IRES-Creþ;Efnb2LacZ/ﬂox embryos (referred
to here as Efnb2 CKO) were recovered at a Mendelian ratio through
stage E11.5, and at just over half the expected ratio between E12.5
and E19 (Supporting Table 1). Live Efnb2 CKO embryos were not
distinguished from control littermates based on size or external
features. As with Efnb2 C-terminal deletion homozygotes (Dravis
et al., 2007), Efnb2 CKO neonates were delivered live, but died
within 12 h of birth. Germline and conditional heterozygote
littermates showed a normal lifespan and no evidence of deafness
or disequilibrium.
The inner ear epithelial labyrinth is derived from a spheroid
otocyst (Fig. 1A,B). The endolymphatic sac (ES) and duct (ED) ﬁrst
appear as an undifferentiated epithelial tube projecting from a
dorso-medial region of the otocyst at stage E10.5 (Fig. 2A,B). Efnb2
CKO otocysts failed to form an endolymphatic epithelium on
schedule (Fig. 2B', asterisk; 10/10 otocysts), as determined by
hybridization of E10.5–10.75 embryo sections with a Gbx2 anti-
sense probe that marks the undifferentiated endolymphatic
epithelium (Lin et al., 2005). At more mature stages, Efnb2 CKO
inner ears showed fully penetrant hypoplasia and dysmorphism of
the ES and ED (n¼72; E12.5–E19; Fig. 2C,C'), fully penetrant
shortening of the cochlear duct (n¼65; E13.5–E19), and otherwise
near-normal size and morphology of the labyrinth through E15.5.
A decrease in average luminal width of Efnb2 CKO vestibular canals
compared to control (31%; po0.002) was ﬁrst noted at stage E17.5
(Fig. 2E,G).
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By E17.5, the endolymph-ﬁlled luminal space of the normal mouse
labyrinth is partitioned into distinct cochlear–saccular–ED–ES and
utricular-canal compartments (Cantos et al., 2000), as assessed by
injection of paint into each of these compartments (Fig. 2D,E). By
contrast, a single injection of paint to the E17.5–18.5 Efnb2 CKO cochlea
ﬁlled the entire endolymph space in 5 of 6 ears (Fig. 2G). In serial
sections of E19 Efnb2 CKO ears, we discovered an abnormal commu-
nication across the base of the ED and common crus of the vestibular
canals (10/14 specimens; E19; Fig. 2H–J), which can account for
unrestricted ﬁlling of the entire mutant labyrinth with one paint
injection to the cochlea. In E17.5–18.5 Efnb2 CKO ears, ducts between
the cochlea and ED – the ductus reuniens and saccular duct (Fig. 2D,F–
H) – were either rudimentary or large in luminal diameter compared
to control, and the proximal segment of endolymphatic epithelium
was variably dilated (Fig. 2H). All sensory epithelia (auditory: organ of
Corti; and vestibular: utricular and saccular maculae, canal cristae) of
Efnb2 CKO ears were present and contained supporting cells and
innervated hair cells (data not shown). Together, these results indicate
that Efnb2 is required for growth and morphogenesis of the ES/ED, as
well as for proper partitioning of the endolymph-ﬁlled lumen of the
fetal inner ear.
Efnb2 loss-of-function affects cell proliferation and survival in the
otocyst epithelium
Since outgrowth of the Efnb2 CKO endolymphatic epithelium is
developmentally delayed (Fig. 2B,B'), we assayed proliferation and
apoptosis in mutant otocysts during the 6–12 h period preceding
normal outgrowth. Stage E10–10.25 Efnb2 CKO otocysts were
hypoplastic (Fig. 3A), and the percent reduction in Efnb2 CKO
Gbx2þ domain area was comparable to that for Efnb2 CKO total
otocyst surface area (Table 1), suggesting that loss of Efnb2 has
wide-spread effects on otocyst growth. Mitotic indices for a
sample of E10 otocysts, obtained by subjective counts of phosho
Histone-H3-(pH-H3)-positive apical mitotic ﬁgures, revealed a 42%
decrease in density of M-phase cells in mutant ears compared to
those of control ears (Fig. 3B). We obtained comparable absolute
and percentage change values for whole otocysts by applying
normalized pixel counts (labeling index) to the same samples
(Fig. 3C), and this approach was used to characterize regional
differences in pH-H3 abundance. At E10, signiﬁcant decreases of
between 42 and 47% in Efnb2 CKO pH-H3 labeling indices
compared to control were found at dorso-lateral (DL) and ventral
(V) regions (Fig. 3C).
We next assessed otocyst cell proliferation by injecting preg-
nant dams with the thymidine analog EdU (10ug/gram weight of
mouse) at the onset of E10 (as deﬁned in Materials and Methods:
Animals) and again 2 h later; embryos were collected and ﬁxed six
hours after the ﬁrst injection (E10.25). At E10.25, we found EdU
fully incorporated into many interphase or apical M-phase nuclei
and partially incorporated (speckling) into a smaller subset of
interphase nuclei (Fig. 3E), suggesting that embryos were exposed
to EdU for much of the six-hour labeling period. Whole Efnb2 CKO
otocysts showed an 18% reduction in EdU labeling index compared
to that of controls, providing further support for a slowing of cell-
cycle kinetics in the mutant otocyst compared to control (Fig. 3D).
By contrast to the E10 pH-H3 regional results, dorso-medial (DM)
and ventral (V) E10.25 EdU mutant regional indices were signiﬁ-
cantly decreased by 17–20% from those of control.
Fig. 1. Distribution of Sox9-IRES-Cre activity and validation of Efnb2 inactivation in otic tissues. (A–D) Sox9-IRES-Creþ;Gt(ROSA)26Sor(EYFP) embryo at E9.5, showing native
reporter ﬂuorescence in a fresh embryo (green, A) and anti-GFP antibody-enhanced reporter signal (green, B–D). Transverse section (B–D) is counter-labeled with
rhodamine-phalloidin (red) and DAPI (blue). Reporter signal is absent in deﬁnitive ectoderm (arrows in C), pharyngeal endoderm (arrows in D), and endothelium of dorsal
aorta (asterisk in D; red cytoplasm). (C,D) correspond to boxed regions in (B). o, otic vesicle; hb, hindbrain. (E,F) Sections through endolymphatic duct of E12.5 Efnb2 CKO
(F) and control (E) littermates, immunolabeled for Efnb2 protein (gray). White brackets highlight retention of signal in marginal zone of the mutant hindbrain (hb). ED,
endolymphatic duct; mes, periotic mesenchyme. (G,H) Sections through endolymphatic duct of E13.5 Efnb2 CKO (H) and control (G) littermates, hybridized to detect Efnb2
exon 1. (I,J) Sections through cochlear duct of E12.5 Efnb2 CKO (J) and control (I) littermates, immunolabeled for Efnb2 protein (gray). coch, cochlear epithelium; mes, peri-
otic mesenchyme spg, spiral ganglion neurites. All controls are Efnb2ﬂox/þ . (E-J) are shown to scale. All sections are in transverse plane.
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Fig. 2. Anatomical abnormalities of the Efnb2 CKO inner ear. (A) Location of the otocyst at mid-gestation and projection of ES/ED rudiment from the dorso-medial otocyst.
Lines show plane of section for (B,B'). (B,B') E10.75 control (Efnb2ﬂox/þ) and CKO littermates, hybridized for Gbx2 mRNA. Bracket in (B) highlights the endolymphatic
projection; asterisk in (B') highlights its absence; open gray arrow in (B) highlights weak Gbx2 signal at the endolymphatic epithelial lateral wall. Scale bar¼50 μm;
hb¼hindbrain. (C,C') Endolymph space of E15.5 control (Creþ;Efnb2ﬂox/þ) and CKO ears (medial views), visualized by paint injection. Endolymphatic epithelia are false-
shaded yellow. Scale bar¼200 μm. (D–H) Endolymph space of E17.5 control ears (Creþ; Efnb2ﬂox/þ; D,E), ﬁlled from either the cochlea (D) or utricle (E). Efnb2 CKO ear (G),
ﬁlled with one injection to the cochlea. Gray wedges indicate injection site. (F and H) are magniﬁed views of boxed regions in (D and G). Yellow arrow and arc in (H) highlight
abnormal continuity across ED and common crus (CC). Asterisks in (H) highlight dysmorphic saccular duct and ductus reuniens. Scale bar in (G)¼400 μm in (D,E,G) and
150 μm in (F,H). Axes in (G) apply to (C–J). (I,J) Toluidine blue stained saggital sections through the head show abnormal luminal continuity (arrow in J) across endolymphatic
epithelium (‘ED’) and common crus (CC) in an E19 Efnb2 CKO ear. (I) shows an Efnb2ﬂox/þ control. Scale bar in (J)¼100 μm and applies to (I,J).
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We next analyzed the distribution of apoptotic bodies by
TUNEL in a sample of E10 otocysts. We found increased TUNEL
in the Efnb2 CKO otocyst compared to control speciﬁcally at a
previously described (Lang et al., 2000) dorsal focus of pro-
grammed cell death (Fig. 3F). However, TUNEL staining of the
Efnb2 CKO endolymphatic epithelium between stages E11.5 and
E14.5 was judged to be unchanged from control. Taken together,
these results correlate Efnb2 loss-of-function with dysregulated
cell proliferation and apoptosis during the 12-hour period of
development preceding outgrowth of the normal endolymphatic
epithelium.
Efnb2 and cognate Eph receptor gene expression patterns deﬁne
speciﬁc regions of the otocyst epithelium
Since growth defects of the Efnb2 CKO ear were apparent as
early as stage E10, we surveyed gene expression of Efnb2 and its
cognate receptors in normal C57BL/6 embryos beginning at stage
E9. The otocyst forms by invagination of an ectodermal (otic)
placode. Efnb2 mRNA expression in the early stage otic epithelium
was regionalized and dynamic (Fig. 4C,J,Q). Comparison of Gbx2
mRNA, Efnb2-tau-lacZ, and Efnb2 mRNA signals found Efnb2-lacZ
histochemical staining and Efnb2mRNA signals at the dorsal rim of
the otic cup, whereas Gbx2 signal was located medial to the Efnb2-
lacZ/Efnb2 dorsal rim signals (Fig. 4A–C; brackets). Regional
complementarity of Efnb2-lacZ/Efnb2 and Gbx2 signals was main-
tained at the dorsal otocyst through the time of otocyst formation
at E9.5 (Fig. 4H,I,J; arrows). However, Efnb2-lacZ and Efnb2 mRNA
signals were re-distributed to the dorso-medial otocyst by E10.25,
resulting in partial overlap with the Gbx2 domain and marking of
the initial outgrowth of endolymphatic epithelium (Fig. 4O,P,Q).
Since fate mapping of chicken embryos places the origin of the
endolymphatic epithelium at the dorsal rim of the otic cup
(Brigande et al., 2000), our results associate Efnb2 transcription
with the earliest known origins of the endolymphatic epithelium.
However, we could not reliably detect Efnb2 cell surface protein in
the E9–E10.25 otic epithelium using a polyclonal antibody that
speciﬁcally labels Efnb2 at later stages (Fig. 1E,F,I,J).
Fig. 3. Altered proliferation and apoptosis in Efnb2 CKO otocysts. (A) E10 Efnb2ﬂox/þ-CKO littermate pair, hybridized for detection of Gbx2 mRNA. (B) phospho-histone-H3
immunolabeling of an E10 control otocyst section. Box and whisker plot summary of mitotic indices for Efnb2ﬂox/þ control (clear box) and CKO (hatched box) whole E10
otocysts (n¼10 otocysts per group), obtained by subjective counts of pH-H3-positive ﬁgures. Whiskers on all plots deﬁne the sample range. Two-tailed P values on all plots
are from unpaired t-tests. (C) Summary of pH-H3 labeling indices for Efnb2ﬂox/þ control (clear boxes) and CKO (hatched boxes) whole otocysts and otocyst regions (n¼10
otocysts per group) at E10, obtained by normalized pixel counts (see Materials and Methods). Non-signiﬁcance (ns) set at P40.05. Schematic at right deﬁnes otocyst regions;
DL, dorso-lateral; DM, dorso-medial; V, ventral. (D) Summary of EdU labeling indices for Efnb2ﬂox/þ control (clear boxes) and CKO (hatched boxes) whole otocysts and
otocyst regions (n¼10 otocysts per group) at E10.25, obtained by normalized pixel counts. (E) EdU incorporation signals from an E10.25 Efnb2ﬂox/þ-CKO littermate pair
processed in parallel. Images at right are magniﬁed views of the dorso-medial otocyst region. (F) E10 Efnb2ﬂox/þ-CKO littermate pair, showing TUNEL signals (red) in the
dorsal otocyst. Axes in (F) apply to all photos.
Table 1
Summarized surface areas (103 square microns) for total otocysts and
Gbx2-positive domains in Efnb2 CKO and control otocysts at stage E10.
Control (mean;sd) Mutant (mean;sd) % Change
Total otocyst area 170.0; 19.3 136.1; 11.8nn 20.0
Gbx2-positive domain area 56.4; 9.9 41.6; 7.2n 26.2
Values (103) refer to surface areas measured at the epithelial basement
membrane for regions of interest.
nn Po0.01.
n Po0.02, by unpaired 2-way t-tests, n¼6 for each sample.
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Cognate Eph receptor mRNA signals were either not detected or
were relatively reduced in signal intensity at the Efnb2þ dorsal rim
of the otic cup (Fig. 4C–G; brackets). Rough complementarity of
Efnb2 and Ephb2/Epha4 signals was maintained dorsally upon
formation of an otocyst at E9.5 (Fig. 4I–N). Re-distribution of Efnb2
expression to the dorso-medial otocyst by E10.25 resulted in over-
lap with the domains of Ephb2, Ephb4, and Epha4 (Fig. 4P–U).
Detection of Efnb2 and Eph receptor gene expression within the
early-stage otic epithelium is consistent with our ﬁndings of otocyst
stage growth defects in the Efnb2 CKO.
Efnb2 loss-of-function affects epithelial folding and gene expression at
the nascent endolymphatic epithelium
After a delay in outgrowth, the Efnb2 CKO endolymphatic
epithelium attained roughly 80% of control length (proximal–
distal, measured at medial wall) by E12.5 (Fig. S1). We therefore
characterized the mutant structure between stages E10.5 and
E12.5 to probe developmental events subsequent to growth
initiation. Normally, the dorsal otocyst forms endolymphatic and
vertical canal plate epithelia, the latter a rudiment for vestibular
canals and the associated common crus. Morphogenic events
distinguishing the normal endolymphatic epithelium from vertical
canal plate involve folding and invagination of dorsal otic epithe-
lium (Figs. 5A and 4P,Q), and the ventral edge of the invagination
fuses with another region of otic epithelium at E16.5 to partition
the endolymph-ﬁlled lumen (data not shown). Depth of invagina-
tion at the E11.5–11.75 Efnb2 CKO otocyst was markedly reduced
compared to control (8/8 otocysts; Fig. 5B arrowheads). By E12.5,
the depth of mutant invagination was abnormally shallow but
comparable to that of control (10/10; Fig. 5H,H', arrowheads);
however, the proximal segment of the invagination (ED lateral
wall) was hypocellular and lacked normal low columnar form
(Fig. 5C).
We asked whether deﬁcient morphogenesis correlates with
changes in expression of genes required for development of the
endolymphatic epithelium. Foxi1 mRNA marks prospective ion-
transporting MRCs of the developing endolymphatic sac (Hulander
et al., 2003). Foxi1 mRNA is ﬁrst detected at the lateral (invagi-
nated) wall of the normal endolymphatic projection at E10.5
(Ohyama and Groves 2004) and within the domain of Efnb2
expression (Fig. 5D,E). As expected, the E10.5 Efnb2 CKO dorsal
otocyst showed no evidence of folding or invagination. Foxi1
mRNA signal appeared without developmental delay within the
region of Efnb2 transcription, but was mis-localized to the medial
side of the mutant dorsal otocyst (Fig. 5D',E';).
The homeodomain-containing genes Gbx2 and Dlx5 are
required for normal growth of the endolymphatic epithelium
(Lin et al., 2005; Depew et al., 1999; Acampora et al., 1999;
Merlo et al., 2002; Sajan et al., 2011), and expression of Dlx5 at
the dorso-medial otocyst requires Gbx2 activity (Lin et al., 2005).
In wild-type embryos at E12, the Gbx2þ domain formed an
intensity gradient across the proximal two-thirds of the endolym-
phatic epithelial medial wall, and it extended to proximal regions
of the lateral (invaginated) ED wall (Fig. 5F; bracket and arrow-
heads). Thus, Gbx2 appears to mark the early-stage deﬁnitive ED.
In mutant littermates, the Gbx2þ domain was truncated at the
medial wall and did not extend to regions that ultimately form the
ED lateral wall (Fig. 5F'). In contrast to Gbx2, normal Dlx5 mRNA
signal formed an intensity gradient across the entire proximal–
distal length of the endolymphatic epithelium, with intensity
decreasing distally (Fig. 5G,H). In stage-matched mutants, Dlx5
mRNA signal intensity was attenuated speciﬁcally at the proximal
(ductal) segment of epithelium compared to control (Fig. 5G',H').
RNA hybridization on earlier stage Efnb2 CKO otocysts (E9.5–
E10.25) revealed no change in Dlx5 signal intensity compared to
control (data not shown). Taken together, deﬁcient folding and
invagination of the Efnb2 CKO dorsal otic epithelium correlate with
mis-localized initiation of Foxi1, a gene required for ES MRC
differentiation (Hulander et al., 2003), and altered expression of
Gbx2 and Dlx5, both of which inﬂuence endolymphatic epithelial
growth (Lin et al., 2005; Depew et al., 1999; Acampora et al., 1999;
Merlo et al., 2002; Sajan et al., 2011).
Fig. 4. Comparative developmental expression of Gbx2, Efnb2, and cognate Eph
receptor mRNA. (A–G) Comparative gene expression at the otic cup. Brackets
highlight the Efnb2þ dorsal rim of the otic cup. (H–N) Comparative gene expression
at the newly formed otocyst. Open arrows highlight the medial-lateral midline of
the dorsal otocyst. (O–U) Comparative expression at the later-stage otocyst, which
shows ﬁrst indications of endolymphatic epithelial outgrowth and folding of the
dorsal otocyst (red arrows in P,Q). All panels show RNA hybridization signals,
except for (B,I,P), which shows Efnb2-lacZ histochemical staining. (A–N) are shown
to scale. (O–U) are shown to scale. Axes in (H) apply to all panels.
S. Raft et al. / Developmental Biology 390 (2014) 51–6756
Efnb2 loss-of-function affects regionalization of the endolymphatic
epithelium into sac and ductal components
Having identiﬁed early-stage effects of Efnb2 loss-of-function on
gene expression at the endolymphatic epithelium, we asked
whether overt differentiation of the ES and ED is affected in the
perinatal stage Efnb2 CKO. In wild-type embryos between E11.5 and
E15.5, Efnb2 mRNA and gene product, together with Ephb2 and
Epha4 mRNA signals, were progressively restricted to the ED
(proximally), whereas Foxi1 mRNA signal formed a mosaic pattern
distally at the ES (Fig. S2). Slc26a4, encoding the anion exchanger
pendrin, is activated by the Foxi1 transcription factor and marks
ion-transporting MRCs in the fetal endolymphatic sac (Hulander
et al., 2003; Yang et al., 2007; Dou et al., 2004). In E19 controls,
Slc26a4 signals were conﬁned to the distal third of the endolym-
phatic epithelium (ES) and a small domain where the ED joins the
sacculus (saccular duct (Kim and Wangemann 2011)), but the
mutant epithelium expressed Slc26a4 along its entire proximal–
distal length (Fig. 6A,A'). To conﬁrm that dysregulated Slc26a4
signal in the Efnb2 CKO represents ectopic localization of ES MRCs,
we double-labeled ears from E19 mutant mice and control litter-
mates with antibodies against pendrin and either Foxi1, v-Hþ-
ATPase subunits, or Carbonic anhydrase II (CAII), as the latter
proteins are detected speciﬁcally in ES MRCs (Fig. 6B, data not
shown; (Dou et al., 2004)). In all cases, distal/ES co-localization
proﬁles were found throughout the entire proximal–distal length of
the mutant endolymphatic epithelium (Fig. 6B–D), with the excep-
tion that a small proximal rostro-medial region of the mutant
endolymphatic epithelium did not display ES markers (Fig. 6C,
arrows). Proximal mis-localization of ES markers occurred in
mutants as young as stage E12.5 (data not shown). Apical plasma
membrane co-localization of pendrin and v-Hþ-ATPase, as well as
nuclear localization of Foxi1, was maintained in proximal cells of the
mutant epithelium (Fig. 6C,D), suggesting that these proximal cells
are functional acid–base secretory cells (MRCs) of an ES lineage.
Since Foxi1 is required for expression of the Notch ligand gene
Jagged1 in the ES (Hulander et al., 2003) and Notch signaling (Fortini
2009) regulates Foxi1 ortholog expression in developing aquatic
vertebrates (Janicke et al., 2007; Quigley et al., 2011), we asked
whether spatial dysregulation of activated Notch signaling correlates
with the ectopic expression of Foxi1 in the Efnb2 CKO. We surveyed
expression of the known mouse Notch receptor genes in the normal
endolymphatic epithelium at E14.5 by RNA in situ hybridization and
found strong signal for Notch1 and Notch3. We therefore double
labeled Efnb2 CKO and control littermates at E14.5 with antibodies
against Foxi1 and the cleaved (Val1744) Notch1 intracellular domain
Fig. 5. Altered morphogenesis and gene expression at the Efnb2 CKO dorsal otic epithelium. (A) Histology of E12 dorsal otic epithelium in the transverse plane. Curved
arrows indicate prior-stage folding and invagination to form the ED and vertical canal plate (vCP). Red arrow highlights ventral edge of invagination. Axes apply to all photos.
(B) Sections from an E11.75 Efnb2ﬂox/þ-CKO littermate pair, labeled with phalloidin and DAPI. Arrowheads highlight ventral extent of invagination. (C) High power views of
proximal segments from the lateral ED wall of an E12.5 Efnb2ﬂox/þ-CKO littermate pair. Magenta dots indicate individual nuclei. (D–E') Efnb2ﬂox/þ–CKO littermate pair
hybridized to detect Foxi1 or full-length Efnb2. The recombined Efnb2 ﬂoxed allele produces non-translated transcript, allowing domains of Efnb2 transcription to be
identiﬁed in the null mutant (D'). Dorsal otocyst epithelium is outlined in red. Arrowheads in (E,E') highlight the location of initial Foxi1mRNA signal. (F–H') RNA-hybridized
sections from Efnb2ﬂox/þ-CKO littermate pairs, shown to scale. Brackets in (F,F') highlight proximal–distal extent of Gbx2 signal. Arrowheads (F) highlight Gbx2 signal at the
ED lateral wall. Asterisks in (G,G') highlight the ES. Arrows in (H') highlight attenuated Dlx5mRNA signal. Arrowheads in (H,H') highlight ventral extent of invagination; ﬁelds
in (H,H') are aligned relative to the horizontal crista (hc). vCP, vertical canal plate.
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(ICD). Robust nuclear Notch1-ICD signal was present in Foxi1-
negative nuclei of the control ES, but not in nuclei of the control
ED (Fig. 6E,F). By contrast, we found robust nuclear Notch1-ICD signal
throughout the proximal–distal axis of the mutant endolymphatic
epithelium, especially in nuclei adjacent to ectopic Foxi1þ nuclei
(Fig. 6F, right panels; compare with Fig. 6E). We also surveyed
expression of the Notch target genes Hes1, Hes5, Hey1, Hey2, and
HeyL in the normal endolymphatic epithelium at E14.5 by in situ
hybridization and found signal for Hes1 and HeyL only in the
endolymphatic sac, with Hes1 the more abundant of these two
signals (data not shown). We therefore assessed Hes1 expression in
Efnb2 CKO-control littermate pairs at E14.5 and found ectopic Hes1
mRNA signal in the proximal segment of the mutant epithelium
(Fig. 6G). Foxi1-dependent MRC differentiation and Notch pathway
activation are thus coordinately mis-localized by loss of Efnb2. These
results suggest that the Efnb2 CKO fails to form a differentiated ED
epithelium.
Conditional inactivation of Notch signaling affects Foxi1þ cell density
but not proximal–distal regionalization of the endolymphatic
epithelium
As just shown, most of the Efnb2 CKO endolymphatic epithe-
liumwas distalized in its molecular proﬁle, but the total number of
Fig. 6. Failed proximal–distal (duct–sac) regionalization of the Efnb2 CKO endolymphatic epithelium. (A) Distributions of Slc26a4 mRNA signals along the proximal–distal
length of endolymphatic epithelium for E19 Efnb2 CKO and control littermates. Error bars show standard deviation. (A') Discrete Slc26a4 signals in a control epithelium. (B,C)
Saggital sections through control (Efnb2þ /ﬂox, B) and Efnb2 CKO (C) E19 littermate heads, double immunolabeled for Foxi1 and pendrin. Distal/ES is toward the top.
Horizontal lines mark level of insertion into the sacculus (s). Arrows in (C) highlight a proximal rostro-medial segment lacking ectopic signal. Inset in C shows proximal
mutant cells (lumen is left). cc, common crus. (D) Control (Efnb2þ /ﬂox) and Efnb2 CKO E19 littermates, double immunolabeled for pendrin and either B1/B2 subunits of the
vesicular proton pump or carbonic anhydrase II. CKO ﬁelds are of proximally (prox) located cells (lumen is left). (E,F) Control (Efnb2þ /ﬂox) and Efnb2 CKO E14.5 littermates,
double immunolabeled for Foxi1 and cleaved Notch1-ICD. Lower panels in F show boxed regions in upper panels. Lower left panel in (F) highlights basal cytoplasmic Notch1-
ICD signal in the control duct. (G) Transverse sections of control and CKO E14.5 littermates, hybridized for Hes1. Arrows highlight a proximal medial segment lacking ectopic
signal. cc, common crus. Axes in (G) apply to (E–G).
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DAPIþ nuclei within the mutant Foxi1þ domain was decreased
compared to control at stage E14.5 (Table 2). Therefore, loss of
Efnb2 causes a complex growth deﬁciency of both sac- and ductal-
type tissues, with a differentially severe effect on formation of
proximal/ductal-type tissue. Data from two developmental stages
revealed that Efnb2 loss-of-function does not affect the local
density of Foxi1þ MRCs (Table 2).
Notch signaling inﬂuences embryonic tissue growth, compart-
mentalization, and ﬁne-scale patterning (i.e., density) of cells
within developing tissues, so we asked whether Notch signaling
mediates the effects of Efnb2 on growth or regionalization of the
endolymphatic epithelium. We analyzed the developing endolym-
phatic epithelium of a previously characterized Foxg1-Cre-
mediated Rbpj CKO (Yamamoto et al., 2011), which inactivates
canonical Notch signaling in the early otocyst epithelium. By RNA
hybridization, the E15.5 Rbpj CKO ES showed decreased intensity
and extent of Hes1 signal compared to control (Fig. S3A,A'),
suggesting that Notch signaling is disrupted in the developing
ES. By immunoﬂuorescence, we found no apparent change in
Efnb2 protein expression at Rbpj CKO endolymphatic epithelia
(data not shown), suggesting that Efnb2 acts upstream of or in
parallel to Notch signaling during development of the ED/ES.
Notably, neither proximal–distal ED/ES length nor regionalization
of Foxi1 and pendrin epitopes differed between Rbpj CKO and
littermate controls at E15.5 (Fig. S3B,B'). However, Foxi1þ cell
density in the E15.5 Rbpj CKO ES was increased by over 2-fold
compared to control; this correlated with a speciﬁc hypoplasia of
the ES epithelium and a pronounced decrease in absolute number
of Foxi1-negative nuclei within the ES (Fig. S3C,C'; Table 2). Taken
together, these results suggest that canonical Notch signaling does
not mediate the effects of Efnb2 on global growth and regionaliza-
tion of the endolymphatic epithelium. However, Notch signaling is
required for establishing a normal ratio of Foxi1-positive to Foxi1-
negative cells within the developing ES epithelium.
Efnb2 loss-of-function disrupts an early phase of otoconial biogenesis
We next used the Efnb2 CKO to characterize inner ear structural
abnormalities that might result from mis-localized ES MRCs.
Targeted null homozygosity of Foxi1, Slc26a4/pendrin, or the
proton pump subunit gene Atp6v0a4 causes defects in otoconia
of the utricle and saccule (Everett et al., 2001; Nakaya et al., 2007;
Dror et al., 2010; Li et al., 2013; Hulander et al., 2003; Norgett et al.,
2012). Otoconia are extracellular biominerals with a proteinaceous
core and calcitic outer shell, and their biogenesis within the
endolymph is sensitive to pH and ionic conditions (Hughes et al.,
2006; Thalmann et al., 2001). At E19, both mutant and control
otoconia had an inorganic outer shell, as determined by birefrin-
gence patterns under polarized light, and core glycoprotein con-
stituents, as determined by toluidine blue staining of thin-
sectioned specimens (data not shown). Polarized light microscopy
of dry frozen sections indicated that both the utricle and saccule of
Efnb2 CKO fetuses contained fewer and larger otoconia than those
of controls (data not shown). Analyses of E19 utricles by scanning
electron microscopy (SEM) conﬁrmed abnormalities in size, num-
ber, and shape of mutant otoconia. Control (Efnb2þ /ﬂox) otoconia
had the typical barrel-shape and faceted ends, with a ﬁne ﬁbrillar
network running between and along the cortical surfaces of
otoconia (Fig. 7A,E arrowheads). By contrast, Efnb2 CKO otoconia
had either of two major atypical forms, regardless of size (Fig. 7C,
red and cyan arrows), and proteinacious ﬁbrils running between
mutant otoconia were thicker than those of control by an order of
magnitude (Fig. 7D,E arrowheads). Measurements of mutant
utricular otoconia imaged by SEM (n¼6) gave average lengths
ranging between 8 and 135 μm, whereas average otoconial lengths
for Efnb2þ /ﬂox control utriculi ranged between 2.61 and 2.76 μm.
Average otoconial length and number of otoconia per utricle for
the mutant sample showed a strong negative correlation (Fig. 7F).
Extrapolating the curve to a sample-wide mean length (2.67 μm)
measured for control otoconia provided a reasonable estimate
(12,000) for the total number of otoconia in a normal peri-natal
mouse utricle.
We hypothesized that the mass of mutant organic matter
available for pre-otoconial formation is similar to normal, but that
seeding of organic matter for subsequent mineralization is dysre-
gulated. Seeding occurs in the endolymph space by Caþ þ- and
acidic glycoprotein-mediated aggregation of secreted matrix
vesicle-like structures (globular substance) (Hughes et al., 2006;
Thalmann et al., 2001). We therefore characterized the morphol-
ogy of pre-otoconia at E15.5, a stage when the relevant organic
constituents are being secreted by vestibular epithelia into the
endolymph space (Nakahara and Bevelander, 1979; Anniko, 1980).
SEM of controls revealed stereotypical dumbbell-shaped forms
with rough surface morphology (Fig. 7G). By contrast, E15.5 Efnb2
CKO utricles (n¼5) contained either disorganized forms of a
similar size to control, or large atypical forms similar in shape to
the mutant otoconia at E19 (Fig. 7H–J). These results provide
evidence that loss of Efnb2 affects the aggregation of pre-otoconial
organic matter, a process that is sensitive to the ionic composition
of endolymph.
Ectopic MRCs are associated with background strain-speciﬁc
vestibular dysfunction of Efnb2 heterozygotes
The Efnb2 C-terminal truncation allele (ephrin-B2LacZ mice in
(Dravis et al., 2007; Cowan et al., 2004; Dravis et al., 2004); here
referred to as Efnb2 C-del) produces an Efnb2:ß-galactosidase
fusion protein that is targeted to the plasma membrane and binds
cognate EphB receptors on adjacent cells, but is unable to
transduce signals to the cytoplasmic side of the membrane. Both
isogenic CD1 and mixed 129/CD1 Efnb2 C-del homozygotes had a
shortened and dysmorphic endolymphatic duct and sac, with CD1
strain dysmorphism and hypoplasia the more severe of the two
strains. Homozygous mutants of both backgrounds had otoconia
that were large in size and few in number compared to those of
controls (Fig. S4A). Immunoﬂuorescence analyses of 129/CD1
Efnb2Cdel/Cdel fetuses at E19 revealed a proﬁle of molecular
mis-localization identical to that of the Efnb2 CKO mutant; i.e.,
Table 2
Summarized cell counts for Efnb2 CKO and Rbpj CKO mutant and control samples.
Strain/Stage Controla
(mean;sd)
Mutant
(mean;sd)
% Change
Efnb2 CKO
E14.5 (n¼12)b Total nucleic 2719; 363 2396; 338n 11.9
Foxi1þ nuclei 797; 208 603; 116n 14.1
Foxi1þ densityd 290; 50 255; 51 ns
E19 (n¼4) Total nuclei 7645; 1344 5842; 525 ns
Foxi1þ nuclei 1942; 372 1548; 69 ns
Foxi1þ density 241; 26 268; 31 ns
Rbpj CKO
E15.5 (n¼6) Total nuclei 4313; 332 1717; 158nn 60.2
Foxi1þ nuclei 667; 167 575; 96 ns
Foxi1þ density 153; 31 335; 46nn þ118.4
Differences assessed by unpaired t-tests. Two-tailed values of nPo0.05 and
nnPo0.0001.
Non-signiﬁcance (ns) was set at P40.05.
a Controls were Efnb2þ /ﬂox or Foxg1-Creþ;Rbpjþ /ﬂox
b Refers to equally sized control and mutant samples.
c Refers to total number of DAPIþ nuclei within the domain of Foxi1 protein
expression.
d Number of Foxi1þ nuclei per 1000 DAPIþ nuclei.
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MRC markers were found proximally in the endolymphatic
epithelium (Fig. S4B–D; data not shown). As in the Efnb2 CKO,
129/CD1 C-del homozygotes failed to partition the endolymph
space into distinct cochlear-saccular-ED-ES and utricular-
vestibular canal compartments (5/5 ears). As previously shown
(Dravis et al., 2007), vestibular canals were abnormally narrow in
129/CD1 Efnb2 C-del homozygotes. These results indicate that
homozygous loss of the Efnb2 C-terminus elicits many features
of the Efnb2 CKO fetal ear described in preceding sections.
Dravis et al. (2007) characterized incompletely penetrant and
background strain-speciﬁc vestibular-motor dysfunction (circling,
head bobbing) in CD1 Efnb2 C-del heterozygotes, and correlated
this behavior with an ionic abnormality of the endolymph. To
determine whether defective ES/ED development correlates with
vestibular dysfunction, we screened for phenotypes identiﬁed in
this study using three strains of Efnb2 heterozygote mutant
fetuses (CD1 Efnb2 C-del; mixed 129/CD1 Efnb2 C-del; C57BL/6
Efnb2tau lacZ/þ), only one of which (CD1 Efnb2 C-del) shows
head-bobbing and circling (Dravis et al., 2007). All E19 hetero-
zygote endolymphatic epithelia were mildly/moderately hypoplastic
(Fig. 8C,D), with C-del strains more prominently affected than the
C57BL/6 Efnb2tau lacZ/þ . No E19 heterozygotes showed evidence of
large otoconia in either the utricle or saccule under polarized light
microscopy (0/4 fetuses per strain). All E19 heterozygotes of the
circling CD1 Efnb2 C-del strain (4/4) showed Foxi1þ/pendrinþ/v-
Hþ-ATPaseþ/CAIIþ cells in the proximal half of the endolymphatic
epithelium (Fig. 8D–G), while 129/CD1 Efnb2 C-del and C57BL/6
Efnb2tau lacZ/þ heterozygotes did not (0/4 per strain). The mean
number of Foxi1þ/pendrinþ MRCs in the proximal half of CD1 Efnb2
C-del heterozygote endolymphatic epithelia was 17% that for CD1/129
Efnb2 C-del homozygote endolymphatic epithelia. Normal sub-cellular
localization of selected epitopes was retained in mis-localized MRCs of
CD1 ephrin-B2 C-del heterozygotes (Fig. 8E,F). Among all heterozygotes
analyzed, one of four CD1 Efnb2 C-del ears had an abnormal luminal
communication across the base of the ED and common crus. These
results associate dysmorphogenesis of the endolymphatic epithelium
andMRC mis-localization with the overt vestibular dysfunction of CD1
Efnb2Cdel/þ mice.
Discussion
Efnb2 is required for multiple steps in ES/ED development
Growth and morphogenesis of the endolymphatic epithelium
are poorly understood. We have demonstrated that conditional
Efnb2 loss-of-function disrupts: (1) initiation of endolymphatic
epithelial outgrowth; (2) epithelial folding and invagination of the
Fig. 7. Abnormal otoconia in the Efnb2 CKO fetal utricle. (A–E) Control (A,B,E) and Efnb2 CKO (C,D) utricular otoconia at E19. (B) and (C) are shown to scale. Cyan and red
arrows in (C) highlight two prevalent mutant forms; white arrow highlights an intermediate form. White arrowheads in (D, mutant) and (E, control) highlight ﬁbrils between
individual otoconia; note 10-fold difference in scale. (F) Logarithmic plot of mean otoconial length vs. total number of otoconia for six Efnb2 CKO utricular maculae at E19. (G–J)
Pre-otoconia from utricles of E15.5 control (G) and Efnb2 CKO (H–J) littermates. (G–J) are shown to scale.
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dorsal otocyst; and (3) global growth of the endolymphatic
epithelium (Fig. 9). On a more fundamental level, we ﬁnd that
Efnb2 loss-of-function dysregulates otocyst epithelial cell prolif-
eration (globally) and cell survival (focally) during the 12 h of
development preceding normal initiation of endolymphatic
epithelial outgrowth (E10–E10.5). Subsequent to formation of an
endolymphatic epithelium, Efnb2 loss-of-function correlates with:
(1) apparent absence of the ED; (2) mis-localized MRCs; (3) mildly
reduced numbers of MRCs compared to control; and (4) failed
partitioning of the endolymph ﬂuid space into cochlear–saccular–
ED–ES and utricular-canal compartments.
EphrinB–EphB interactions control progenitor cell proliferation
in the intestinal stem cell niche (Holmberg et al., 2006; Genander
et al., 2009), adult hippocampus (Chumley et al., 2007), and
embryonic palatal shelves (Bush and Soriano 2010) through
canonical signal transduction pathways such as Abl-cyclin D1 or
ERK/MAP kinase. Here, using both pulsed EdU incorporation and
an antibody against phosphorylated Histone-H3, we found that
loss of Efnb2 reduces total otocyst epithelial proliferation by
roughly 20–45% at stages E10 (p-Histone-H3) and E10.25 (ﬁxation
for EdU analysis). A regional analysis of proliferation in the dorsal
otocyst was complicated by differing results from the two techni-
ques at E10 and E10.25; additional controlled studies are therefore
necessary to test whether Efnb2 loss-of-function affects prolifera-
tion focally and dynamically in the dorsal otocyst. It is intriguing
that, in the Efnb2 CKO, reduced proliferation at the E10 dorso-
lateral otocyst might be followed by reduced proliferation at the
E10.25 dorso-medial otocyst. This spatio-temporal pattern resem-
bles the observed re-distribution of Efnb2-lacZ and Efnb2 mRNA
signals from dorso-lateral (E9.5) to dorso-medial (E10.25) regions,
and the normal endolymphatic epithelium ﬁrst emerges from the
dorso-medial otocyst at E10.25. A caveat to the hypothesis that
close-range Efnb2 signaling drives proliferation in the early otic
epithelium is our inability to reliably localize Efnb2 protein to
epithelial or periotic mesenchymal cell surfaces during early
otocyst stages, despite clear evidence of Efnb2 mRNA expression
in both tissue layers.
Efnb2 loss-of-function affects epithelial folding/invagination of
the dorsal otocyst and global growth of the endolymphatic epithe-
lium relative to the other major dorsal structure of the late-stage
otocyst, the vertical canal plate. At early stages of normal develop-
ment, we found complementary expression of Efnb2 and cognate
Eph receptor mRNAs in the dorsal otic cup and early otocyst (E9.5).
During organogenesis, epithelial folding and differential growth can
emerge from the more fundamental processes of boundary forma-
tion and compartmentalization (Taylor and Adler, 2008; Simpson
and Morata, 1981), and Eph–ephrin signaling is a well-characterized
mediator of these latter processes (Klein 2012; Batlle and Wilkinson
2012). Interestingly, Brigande et al. (2000) proposed the existence of
a lineage boundary that restricts cell intermingling in the chicken
dorsal otocyst and fate mapped this boundary to the fold distin-
guishing endolymphatic epithelium and vertical canal plate (Fig. 9,
arrowheads).
By contrast, we found no evidence of strictly complementary
Eph–Efnb2 expression along the proximal–distal axis of the
deﬁnitive endolymphatic epithelium between E11.5 and E15.5.
Efnb2/Efnb2 and cognate Eph receptor mRNA expression domains
overlapped proximally in the developing ED and showed graded
reductions in signal intensity more distally (Fig. S2A,B). We there-
fore ﬁnd the conventional model of Eph–ephrin-mediated cell
sorting at a boundary an unlikely explanation for regionalization of
ES and ED components after outgrowth of the epithelium.
Fig. 8. Mis-localization of Foxi1 and ion transport proteins in Efnb2Cdel/þ fetuses of the circling CD1 strain. (A–C) Saggital sections of an E19 CD1 wild-type head, double-
immunolabeled for v-Hþ-ATPase and Carbonic anhydrase II (A) or pendrin and Foxi1 (B,C). (B) corresponds to the box in (C). (D–F) Saggital sections of an E19 CD1 Efnb2Cdel/þ
head, double immunolabeled for pendrin and Foxi1 (D,F) or v-Hþ-ATPase and Carbonic anhydrase II (E). (F) corresponds to the box in (D). Ductal epithelia (A,B,E,F) are
outlined in white. (G) Sums of all positive pixels (means and standard deviations; n¼4 per genotype) for epitopes of interest from the proximal half of the ED in heterozygote
fetuses at E19. Asterisks show signiﬁcant differences (po0.05) by Tukey’s post-hoc multiple comparison tests.
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What could account for MRC mis-localization in Efnb2
mutants? We favor two non-exclusive possibilities, the ﬁrst of
which is delayed endolymphatic epithelial outgrowth and folding
of the dorsal otocyst epithelium. Although developmental timing
of Foxi1 induction is unaffected in the Efnb2 CKO, delayed growth
and folding of the dorsal otocyst correlates with ectopic initiation
of Foxi1 signal at E10.5. Thus, Efnb2-independent morphogenic
events that ultimately form the mutant endolymphatic projection
act on an already mis-localized ES (Foxi1þ) domain. We also
speculate that delayed folding/insufﬁcient invagination of the
Efnb2 mutant dorsal otocyst is a pre-condition to failed partition-
ing of the Efnb2 mutant endolymph space into cochelar–saccular–
ED–ES and utricular-canal ﬂuid compartments (Fig. 2J).
A second possible cause of mis-localized MRCs is differentially
severe growth retardation of the ED relative to the ES at stages
after initial outgrowth, i.e., stages E10.5–E12.5. As stated above,
normal Efnb2 and cognate Eph receptor domains overlap speciﬁ-
cally at the ED. In the Efnb2 CKO, we found Dlx5 mRNA signal
intensity reduced only at the ED, and the ED-speciﬁc Gbx2
expression domain was reduced in absolute size compared to
control. Loss of either Gbx2 or Dlx5 causes deﬁcient growth of the
endolymphatic epithelium (Lin et al., 2005; Depew et al., 1999;
Acampora et al., 1999; Merlo et al., 2002; Sajan et al., 2011), but
whether these genes are required for differential growth of ED and
ES components is not yet known.
Our results indicate that Efnb2-dependent growth and mor-
phogenesis of the endolymphatic epithelium are not mediated by
Notch signaling, since blockade of Notch signaling by conditional
inactivation of Rbpj did not phenocopy the Efnb2 CKO ED/ES.
Conversely, Efnb2 is unlikely to mediate decisions involved in
generating the two major ES cell types, MRCs and Foxi1/
pendrin/vH-ATPaseB1 ribosomal-rich cells (Peters et al.,
2002). For example, the Efnb2 CKO endolymphatic epithelium
showed no change in Foxi1þ MRC density compared to control;
this differs from the Rbpj CKO phenotype of increased MRC density
and reduction in absolute number of non-MRC-type ES cells
compared to control. In the Efnb2 CKO, nuclear Foxi1 and
Notch1-ICD/Hes1 signals were identically mis-localized across
the epithelium, and the normal ﬁne-grained pattern of these
signals (from cell to cell) was preserved in the proximal mutant
epithelium. Finally, normal sub-cellular localization of pendrin and
the vHþ-ATPaseB1 subunit was retained in proximal MRCs of
Efnb2 mutant ears, suggesting that these are functional ion
transport cells.
Efnb2 inﬂuences endolymph homeostasis through effects on inner ear
development
Previous studies indicate that the ES – and MRCs in particular –
mediate endolymph homeostasis. Rodent ES physiology and mor-
phology is altered in response to experimental manipulation of
endolymph volume (Rask-Andersen et al., 1999; Salt and DeMott,
2000). ES MRCs exhibit ultrastructural features similar to those of
acid–base transporting renal intercalated cells (Peters et al., 2002).
Like renal intercalated cells, MRCs require the Foxi1 transcription
factor for differentiation (Hulander et al., 2003), and MRCs target
Fig. 9. Summary of otic epithelial molecular expression and developmental anatomy in normal and Efnb2 CKO embryos. Graphics schematize the entire otocyst (early stages)
or dorsal portion of the otic epithelium as seen in transverse section through embryos at speciﬁed stages. Colored bars or dots represent gene and/or protein expression, as
depicted in the boxed key. Red annotations highlight features of normal development. Blue annotations highlight abnormal features of the mutant. Gray arrowheads
highlight the edge of epithelial fold distinguishing endolymphatic epithelium from vertical canal plate or common crus (after stage E12.5). Graphics do not imply loss of
Ephb2 signal in the Efnb2 CKO. See Discussion for details.
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both the anion exchanger pendrin and protein subunits of the
vesicular proton-translocating ATPase to speciﬁc plasmalemmal
domains (Royaux et al., 2003; Dou et al., 2004; Blomqvist et al.,
2004; Vidarsson et al., 2009). Targeted null homozygosity of
Slc26a4 (encoding pendrin) results in an increased volume and
acidiﬁcation of the endolymph, as well as abnormally large
otoconia (Everett et al., 2001; Nakaya et al., 2007; Dror et al.,
2010; Kim and Wangemann 2011); these defects are rescued by
transgenic replacement of SLC26A4 speciﬁcally in ES MRCs (Li
et al., 2013).
We have correlated mis-localization of Foxi1þ/pendrinþ/vHþ-
ATPaseB1þ/CAIIþ MRCs in the Efnb2 CKO with structural evidence
of abnormally aggregated pre-otoconial matter at E15.5 and large
otoconia at the time of birth. Previous evidence suggests that a
lack of pendrin-mediated HCO3– secretion in Slc26a4/ mice
elevates [Caþ þ] in vestibular endolymph by inhibiting its uptake
through acid-sensitive TRPV5/6 channels (Nakaya et al., 2007).
Dysregulation of otoconial formation is also observed in mice
lacking Foxi1 (Hulander et al., 2003) or the vesicular proton-
translocating ATPase subunit a4 (Norgett et al., 2012). It is
presently unclear why mis-localization and a mild decrease from
the normal number of MRCs should cause an otoconial phenotype
resembling that associated with MRC absence (Foxi1 /) or
dysfunction (Slc26a4 /; Atp6v0a4 /). Loss of an insulated ES
luminal microenvironment due to absence of the ED is one
possible explanation for this (see below).
Heterozygotes of the CD1 Efnb2 C-del strain exhibit partially
penetrant vestibular-behavioral dysfunction from the onset of
ambulation (Dravis et al., 2007). This is attributed to abnormal
ionic composition of the vestibular endolymph (low [Kþ]) and
collapsed semi-circular canals (Dravis et al., 2007), the latter a
likely secondary consequence of abnormal endolymph. In asses-
sing CD1 Efnb2 C-del heterozygotes and heterozygotes from two
other non-circling Efnb2 mutant stains, we found proximal mis-
localization of MRCs only in fetuses of the circling CD1 C-del strain.
This phenotype was mild compared to that of Efnb2 homozygote
mutants, and we did not ﬁnd a gross otoconial defect in CD1 C-del
heterozygotes. Mis-localization of MRCs in CD-1 C-del heterozy-
gotes may therefore exert a more direct endolymph-mediated
inﬂuence on vestibular hair cell function.
MRC mis-localization in CD1 C-del heterozygotes may in itself
be insufﬁcient to cause vestibular-behavioral dysfunction: all four
fetuses analyzed in this study had mis-localized MRCs, but roughly
one-quarter of adult animals display circling/head-bobbing (Dravis
et al., 2007). Interestingly, one of four CD1 C-del heterozygotes
showed failed partitioning of the endolymph ﬂuid space into
distinct cochlear–saccular–ED–ES and utricular-canal compart-
ments. A defect of this sort might disrupt chamber-speciﬁc ionic
concentrations and convective ﬂow of endolymph during head
movement.
Precisely how the ES epithelium controls endolymph home-
ostasis and whether the ED also transports water or solutes remain
unknown. The ED provides a path of communication between
endolymph-ﬁlled chambers of the inner ear and the ES lumen.
However, the narrow lumen of the ED may also retard diffusion of
solutes and insulate ES luminal contents from other parts of the
ear at states of ﬂuid equilibrium (Salt, 2001). In normal rodents, ES
luminal endolymph ionic concentrations (Lang et al., 2007), pH
(Kim and Wangemann, 2011; Tsujikawa et al., 1992), and protein
content (Rask-Andersen et al., 1999, 1991) differ from that of
endolymph elsewhere in the ear. The apparent absence of an ED in
Efnb2 CKO fetal ears should disrupt these solute gradients and
dilute the ES endolymph microenvironment, thereby affecting ES
homeostatic activity.
Our ﬁndings do not conﬂict with a previous hypothesis –
founded partly on biochemical evidence – that B-ephrins and
EphB2 regulate endolymph homeostasis through PDZ protein-
mediated macromolecular complex formation with aquaporins or
the AE-type anion exchangers (Cowan et al., 2000). From E17.5
through juvenile post-natal stages, EphB2 and ephrin-B2 are
expressed across vestibular dark and transitional cell populations
(Cowan et al., 2000; Dravis et al., 2007), which control endolymph
production and ionic composition at locations distant from the ES
(Lang et al., 2007). Results communicated here show that Efnb2 is
required for ES/ED growth and morphogenesis from stage E10.5, if
not earlier. Ephb2 and Efnb2 mutants may thus be useful in
addressing the question of how ES and dark cell epithelia coop-
erate in normal inner ear development and physiology (Kim and
Wangemann, 2010).
Conclusion
By studying conditional inactivation of Efnb2 in the otic
epithelium and mesenchyme of the head and branchial arches,
we have characterized a possible developmental basis for the
endolymph ﬂuid abnormalities associated with Efnb2 mutation.
Other tissue-speciﬁc deletions are needed to determine whether
cranial neural crest (Adams et al., 2001) or periotic mesenchymal
expression of Efnb2 is speciﬁcally required for ES/ED development.
We have also shown that homozygous deletion of the Efnb2 C-
terminus (C-del) phenocopies the late fetal stage Efnb2 CKO, but
existing evidence argues against a model in which these pheno-
types derive solely from loss of signaling through the Efnb2 C-
terminus (reverse signaling). Previous analyses of adult mice
compound homozygous for kinase-inactive Ephb2 and null Ephb3
alleles indicate that bidirectional EphB–Efnb2 signaling is required
for normal endolymph homeostasis and vestibular function
(Cowan et al., 2000; Dravis et al., 2007). However, developmental
analyses of compound homozygous Ephb2/Ephb3 mutants have
not been conducted. In closing, we have shown that Efnb2 is
required for growth and morphogenesis of the endolymphatic
epithelium. This enhances the usefulness of Efnb2–EphB signaling-
deﬁcient mutants to efforts aimed at understanding congenital
disorders of endolymph homeostasis.
Materials and methods
Animals
C57BL/6 mice carrying the null allele Efnb2-tau-lacZ (Wang
et al., 1998) were bred to C57BL/6 Sox9-IRES-Cre knock-in mice
(Akiyama et al., 2005) to obtain double heterozygotes. Double
heterozygotes were bred to C57BL/6 Efnb2ﬂox/ﬂox mice (Gerety and
Anderson 2002) to obtain Creþ;Efnb2LacZ/ﬂox conditional knock-
outs (CKO) and control littermate embryos. CD1 and 129/CD1
strain control and Efnb2 C-terminal deletion mutant embryos,
wherein β-galactosidase is fused in-frame with Efnb2 coding
sequence (ephrin-B2LacZ mice in (Dravis et al., 2007; Cowan
et al., 2004; Dravis et al., 2004)), were obtained as previously
described from established colonies at the UT Southwestern
Medical Center. Foxg1-Creþ;Rbpj del/ﬂox experimental and Foxg1-
Creþ;Rbpjþ /ﬂox control embryos were obtained as previously
described (Yamamoto et al., 2011) from an established colony at
the National Institute on Deafness and Other Communication
Disorders/NIH. PCR genotyping was performed as previously
described. For all breeding, mice were paired in the afternoon
and vaginal plugs identiﬁed in the early morning of the following
day. Noon on the day of plug identiﬁcation was designated E0.5.
Embryos identiﬁed as E10 were harvested between 10 p.m. and
midnight on the day preceding E10, and fulﬁlled the criterion that
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the otocyst showed no morphological evidence of an endolym-
phatic epithelium. Embryos identiﬁed as E10.25 were harvested
between 6 and 9 a.m. on day 10 and fulﬁlled the criterion that the
otocyst had an identiﬁable dorsal fold. All animal experiments
were carried out in strict accordance with recommendations set
forth in the Guide for the Care and Use of Laboratory Animals of
the National Institutes of Health. Protocols were approved by the
Investigational Animal Care and Use Committees of the National
Institutes of Health and the UT Southwestern Medical Center.
Tissue preparation
Pregnant dams were euthanized with an anesthetic concentra-
tion of CO2 and cervical dislocation. Embryos harvested for
immunoﬂuorescence and in situ hybridization were trimmed
and immersion-ﬁxed overnight in cold 4% paraformaldehyde/PBS
(pH 7.4). Embryos for sectioning were cryoprotected in 30%
sucrose/PBS, frozen in OCT compound (Tissue-Tek), and cut serially
at 7-micron thickness on a Leica CM 3050 S cryostat. Stages E9
through E16.5 were cut in the horizontal plane of the embryo.
E17.5–E19 heads were cut at the mid-sagittal plane prior to
ﬁxation and sectioned in the sagittal plane. Embryos harvested
for histological staining were trimmed and immersion-ﬁxed in
either 4% paraformaldehyde/PBS or Methacarn solution, dehy-
drated and cleared by standard methods, embedded in parafﬁn,
and cut serially at 7-micron thickness on a Leica RM2145 micro-
tome. For toluidine blue staining of otoconia, E19 otic capsules
were immersed in ﬁxative (2.5% glutaraldehyde (EMS), 4% paraf-
ormaldehyde (EMS), 50 mM Hepes buffer, 2 mM CaCl2, 1 mM
MgCl2, 140 mM NaCl) for 2 h at room temperature. After washing,
utricles and saccules were dissected free of cartilage, processed for
embedding in JB4 medium (Polysciences #00226-1), and cut at
0.5 μm thickness on a Leica RM2265 microtome. For visualization
of the endolymph space, whole embryos or fetal heads were
immersed in Bodian’s ﬁxative, washed overnight in absolute
ethanol, and cleared in methyl salicylate. E17.5–18.5 heads were
cut mid-sagitally after Bodian ﬁxation. A 0.4% suspension of white
correction ﬂuid (BiC) in methyl salicylate (i.e., ‘paint’) was injected
through a micropipette into either the mid-turn of the cochlea or
the utricle.
Detection procedures
RNA hybridization to tissue sections was performed in slide
mailers according to standard methods using digoxygenin-labeled
probes in weakly acidic hybridization buffer (pH 4.5), anti-
digoxigenin-AP Fab fragments (Roche 11093274910) in TBST buffer,
and the NBT/BCIP colorimetric substrate reaction in AP buffer at
pH 9.5. EdU incorporation was detected with the Click-iT EdU
Alexa Fluor 488 imaging kit (Molecular Probes #C10337) according
to manufacturer’s instructions; two I.P. administrations of 10 μg of
EdU per gram body weight of pregnant female (midnight and
1:30 a.m. on day E10) were followed by harvesting of embryos at
6–7 a.m (E10.25). TUNEL activity was assessed on ﬁxed 7-micron
sections using the In Situ Cell Death Detection Kit, TMR red (Roche
#12156792910). X-gal staining of lightly ﬁxed intact embryos or
dissected otic capsules was performed according to standard
methods, followed by post-ﬁxation, embedding in OCT compound,
and frozen sectioning of stained material. Parafﬁn sections were
rehydrated and stained with either Toluidine Blue or Alcian Blue/
Fast Red.
RNA probes
Cre-mediated recombination at the ﬂoxed Efnb2 allele was vali-
dated with a 140 bp exon 1-speciﬁc fragment (NM_010111.5, nt
139-278) PCR cloned from C57BL/6 tail DNA and ligated into pCR4-
TOPO vector for in vitro transcription. Wild-type Efnb2 was detected
with a 1 kb probe transcribed from NM_010111.5, nt136-1188. Other
cDNAs used were as follows: Foxi1 (NM_023907, full length coding
region), Hes1 (NM_008235, 1.4 kb coding region plus 5'- and 3'-end
fragment), HeyL (NM_013905, full coding region), Notch1 (NM_008714,
nt4270-5611) Notch2 (NM_010928, nt3732-5181), Notch3 (NM_
008716, nt3605-5072), Notch4 (NM_010929, 1.8 kb intracellular
domain), Slc26a4 (AF167411.1, nt948-1700), Dlx5 (AF022075, 1.3 kb full
length α-form), Gbx2 (NM_010262), Epha4 (NM_007936, nt2782-
4242), Ephb2 (NM_010142), Ephb3 (NM_010143, nt535-1207), and
Ephb4 (BC090839.1, nt988-1947).
Antibodies
The following antibodies were used: goat anti-CAII (C-14, Santa
Cruz; 1:200), rabbit anti-pendrin (H-195, Santa Cruz; 1:250);
mouse monoclonal detecting pendrin (UIRF#01065, MBL Interna-
tional, 1:100); FITC-conjugated goat anti-GFP (GeneTex #26662;
1:200); goat anti-Efnb2 (Neuromics #GT15026, 1:1000); goat anti-
FOXI1 (Abcam #ab20454; 1:500), rabbit anti-V-Hþ-ATPase B1/B2
(H-180, Santa Cruz; 1:200), rabbit anti-cleaved Notch1 (Val1744)
(Cell Signaling #2421; 1:100), goat anti-Epha4 (R&D System
#AF641; 1:200), rabbit anti-phospho Histone H3 (Ser10)
(Cell Signaling; 1:1000); rabbit anti-MyoVIIa (Proteus Biosciences
#25-6790; 1:500), rabbit anti-Prox1 (Millipore #AB5475; 1:1000).
Cross-adsorbed ﬂuorophore- and biotin-conjugated donkey IgG
secondary antibodies (Jackson Immunoresearch) were used at
1:500 and 1:2000, respectively, except for biotin-conjugated
donkey anti-mouse IgG, which was used at 1:5000.
Immunoﬂuorescence on tissue sections
Immunoﬂuorescence on ﬁxed tissue cut to 7-micron thick
sections involved standard PBS washes, PBSþ0.1% TritonX-
100þ10% donkey serum blocking solution (30 min, room tem-
perature), and overnight incubations of primary antibodies at 4 1C
in PBSþ0.1% TritonX-100þ1% donkey serum, with the following
modiﬁcations. CAII/v-Hþ-ATPaseB1-B2, CAII/mouse anti-pendrin
and v-Hþ-ATPaseB1-B2/mouse anti-pendrin double labeling was
initiated with a 5-minute incubation of sections in 1% SDS for
antigen retrieval, followed by copious washing. Goat anti-Efnb2
(raised against the extracellular domain) was applied to tissues for
1 h at room temperature with detergent-free blocking and diluent
buffers, followed by biotin-conjugated secondaries and TSA Fluor-
escence Systems tyramide signal ampliﬁcation (Perkin Elmer
#NEL701). Tyramide substrate reactions for all antibodies lasted
16 min. FOXI1/rabbit anti-pendrin and FOXI1/Notch1-ICD double
labeling and phospho-HistoneH3 single labeling were initiated
with antigen unmasking by boiling in citrate buffer (pH 6) plus
0.05% Tween-20 for 20 min, followed by continued incubation in
the same solution as it cooled for another 20 min at room
temperature. Rabbit anti-pendrin, anti-cleaved Notch1-ICD, and
anti-phospho Histone H3 signals were ampliﬁed using a biotin-
conjugated secondary (1:2000) and the Fluorescein TSA system as
described above. All mouse monoclonal antibody applications
were preceded by incubation with unconjugated monovalent Fab
fragment donkey anti-mouse IgG (Jackson Immunoresearch # 715-
007-003; 1:50) for 1 h at room temperature, a quick PBS rinse,
15-minute post-ﬁxation in 4% paraformaldehyde, and 55 min
washes in PBS. Slides were mounted using Prolong Gold anti-fade
with DAPI (Invitrogen #P36931) and #1.5 glass coverslips, and
imaged with a Zeiss LSM-780 confocal laser-scanning microscope.
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Quantitative ﬂuorescence confocal laser scanning microscopy
Measurements of epitope abundance (for pH-H3 and EdU
labeling indices; Foxi1þ nuclei, DAPIþ nuclei) were obtained by
summing automated pixel counts from ﬂuorescence images sam-
pling serial section sets. A mutant-control littermate pair was
serially sectioned on the same day. Each slide for a littermate pair
contained mutant and control sections, distributed in equal
proportions across the minimum number of slides needed to
uniformly sample entire domains of interest from every second
7-micron serial section. Mutant and control sections were rando-
mized in their placement from slide to slide. Within an imaging
session, mutant and control sections were captured in alternation.
The total number of ﬁelds sampling an entire domain of interest
varied according to stage (mean7sd¼17þ/2 ﬁelds/ear for pH-
H3 or EdU at E10–10.25; 22þ/5 for Foxi1 at E14.5–15.5; 32þ/
8 for Foxi1 at E19). Data were collected with a Plan-NEOFLUAR
40 /1.3 oil objective (for anti-FOXI1 and pH-H3) or a Plan-
APOCHROMAT 20 /0.8 dry objective (for Alexa-488-EdU) on a
Zeiss Oberver.Z1 and LSM-780 confocal laser-scanning microscope
controlled by ZEN 2010b software. A 561 DPSS laser excited
Rhodamine Red-X (Jackson Immunoresearch) (anti-FOXI1) and a
488 Argon laser excited ﬂuorescein (tyramide ampliﬁed anti pH-
H3) or Alexa 488 (EdU). GaAsP photodetectors were used. Integra-
tion mode line-scan acquisition parameters included a frame size
of 20482048 pixels, pixel dwell time of 1.58 μs, and pixel
averaging of 4 at 16 bit depth. Each ﬁeld was acquired as a single
optical plane with pinhole size set to 1AU for the 488 nm line. The
optical plane for each ﬁeld was chosen objectively and without
reference to the epitopes of interest by maximizing the number of
DAPI pixels in the ﬁeld during ﬁne focusing (collimator adjusted at
the beginning of imaging session). Laser power and gain settings
were unchanged during imaging of any one slide. Small changes in
Master Gain were made between slides if necessary. Other settings
were largely unchanged across biological replicates for a particular
epitope or epitope pair.
Fluorescence image data analyses
Thresholding and Bezier curves were used to select signal from
non-signal in the raw Zeiss LSM ﬁle format (Zen, 2010b). Thresh-
olding was held constant across all specimens processed in parallel
(within-batch) and, if necessary, modiﬁed slightly across proces-
sing batches. Each processing batch comprised an equal number of
experimental and control specimens. For pH-H3 and EdU signals,
automated counts of total pixels for the channel of interest and
DAPI were summed across ﬁelds for each specimen. To obtain a
normalized index of pH-H3 or EdU labeling for each specimen, the
summed pH-H3 or EdU signal for a specimen was divided by the
specimen’s summed DAPI pixel count. Normalized values were
grouped by genotype and subjected to two-tailed unpaired t-tests.
To assess absolute numbers of Foxi1þ nuclei in the endolymphatic
epithelium, automated pixel counts of nuclear Foxi1 signal (colo-
calizing with DAPI) were summed across ﬁelds for each specimen.
The sum of nuclear Foxi1þ pixels for a specimen was then divided
by a conversion factor estimating the average number of Foxi1þ
pixels per positive nucleus. The Foxi1 conversion factor (2520
pixels/nucleus) was obtained using the freehand selection tool in
ImageJ to sample more than 1200 DAPIþ nuclei from control and
mutant specimens colocalizing with 25 or more Foxiþ pixels.
These same freehand selections provided a conversion factor for
the number of DAPIþ pixels per nucleus (3048 pixels/nucleus).
Absolute numbers of nuclei and Foxi1 nuclear densities were
grouped by genotype and subjected to two-tailed unpaired t-tests.
Scanning electron microscopy
Fetal heads were cut mid-sagittally and immersed in ﬁxative
(2.5% glutaraldehyde (EMS), 4% paraformaldehyde (EMS), 50 mM
Hepes buffer, 2 mM CaCl2, 1 mM MgCl2, 140 mM NaCl) for 2 h at
room temperature. Shortly after immersion, the brain was
removed and a small volume of ﬁxative was injected into the ear
with a needle. After washing, utricles with anterior and lateral
ampullae attached were dissected free of the otic capsule, sub-
jected to osmium tetroxide/tannic acid post-ﬁxation (OTOT, each
step for 1 h with 35 min washes with distilled water between
each step), ethanol dehydration, and critical point drying from
liquid CO2. Specimens were mounted on stubs and the utricular
roof was lifted with a tungsten needle to expose the macula.
Preparations were sputter-coated with platinum and viewed on a
Hitachi S-4800 ﬁeld-emission scanning electron microscope at
5 kV acceleration voltage.
Measurements from scanning electron and light micrographs
Measurements of otoconial lengths, vestibular canal diameters,
endolymphatic epithelial lengths, Gbx2þ domain areas, and total
otocyst surface areas were made in ImageJ. Spatial distributions of
Slc26a4 signals and endolymphatic epithelial lengths were
obtained from automatically aligned images of serial sections
(Autoaligner, BitplaneAG). The endolymphatic epithelial length
for a specimen was obtained by averaging the three longest
lengths measured from a serial section set. For E11.5–12.5 speci-
mens, the Gbx2 expression domain ventral border (at the medial
wall of the otocyst) was used to mark the proximal extent of the
endolymphatic epithelium. Morphological criteria were used for
these measurements at later stages.
Statistics
Two-tailed, unpaired t-tests were used to assess differences in
pH-H3 and EdU labeling indices, absolute counts of DAPIþ or
Foxi1þ nuclei, and Foxi1þ nuclear densities, with statistical
signiﬁcance set at the 95% conﬁdence level. Repeated measures
one-way ANOVAs with Tukey’s multiple comparison post-test
were applied to summed pixel data for Efnb2 C-del and null
heterozygotes.
Figure preparation
Fluorescence confocal microscopic images were optimized
uniformly by applying a 0.45 gamma setting prior to export from
Zen 2010. Further brightness/contrast optimization of confocal
microscopic images, and brightness/contrast optimization of scan-
ning electron and light micrographs was carried out in Photoshop
after ﬂattening all mutant-control photo comparisons to a single
layer. The Unsharp mask and Hue/Saturation tools (Photoshop)
were also applied uniformly to mutant and control DIC images of
RNA-hybridized tissue.
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